A Randomized, Open-label, Parallel-Group, Comparative Study in Chinese Healthy Male Subjects to Evaluate the Safety and Pharmacokinetic Profile of TG103 Injection Produced by Two Different Manufacturing Processes
This study is designed to evaluate the comparability of TG103 injection subject to changes in the manufacturing process in Chinese healthy male subjects.
100 项与 石药集团百克(烟台)生物制药有限公司 相关的临床结果
0 项与 石药集团百克(烟台)生物制药有限公司 相关的专利(医药)
100 项与 石药集团百克(烟台)生物制药有限公司 相关的药物交易
100 项与 石药集团百克(烟台)生物制药有限公司 相关的转化医学